Risk Factors for Pseudoaldosteronism with Yokukansan Use: Analysis Using the Japanese Adverse Drug Report (JADER) Database

被引:22
作者
Ishida, Tomoaki [1 ]
Kawada, Kei [1 ,2 ]
Morisawa, Shumpei [1 ,2 ]
Jobu, Kohei [1 ]
Morita, Yasuyo [1 ]
Miyamura, Mitsuhiko [1 ,2 ]
机构
[1] Kochi Med Sch Hosp, Dept Pharm, 185-1 Kohasu,Oko Cho, Nankoku, Kochi 7838505, Japan
[2] Kochi Med Grad Sch, Dept Biomed Sci, 185-1 Kohasu,Oko Cho, Nankoku, Kochi 7838505, Japan
关键词
yokukansan; Japanese Adverse Drug Report; pseudoaldosteronism; kampo formula; HYPOKALEMIA; PLASMA; SERUM; ACID;
D O I
10.1248/bpb.b20-00424
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Yokukansan is a Kampo formula that is commonly used by the elderly because it is expected to improve peripheral symptoms of dementia and delirium. However, side effects from its use are frequently reported in the elderly. In particular, pseudoaldosteronism caused by the licorice contained in yokukansan leads to hypertension, hypokalemia, and muscle weakness, which may result in death. This study aimed to identify the risk factors of pseudoaldosteronism with yokukansan use. Using cases reported in the Japanese Adverse Drug Report (JADER) database, the reporting odds ratio (ROR) was calculated and compared to assess the risk of pseudoaldosteronism for each licorice-containing Kampo formula. We also analyzed the risk factors for pseudoaldosteronism in patients taking yokukansan. Yokukansan (ROR 2.4, 95% confidence interval (CI) 1.9-2.8; p < 0.001) had a higher risk of pseudoaldosteronism than that of other licorice-containing Kampo formulas. Furthermore, the results of a logistic regression analysis in patients taking yokukansan showed that the licorice dose (OR 1.5, 95% CI 1.2-2.0; p < 0.01), older age (<70 years, OR 5.9, 95% CI 1.8-20; p < 0.01), dementia (OR 2.8, 95% CI 1.6-4.9; p < 0.001), low body weight (<50 kg, OR 2.2, 95% CI 1.1-3.5; p = 0.034) were risk factors for pseudoaldosteronism, Although not significant, treatment with loop diuretics (OR 1.8, 95% CI 0.98-3.5; p = 0.059) tended to increase the risk of pseudoaldosteronism. In summary, patients must understand the risk factors when considering taking yokukansan and reduce the licorice dose they consume.
引用
收藏
页码:1570 / 1576
页数:7
相关论文
共 24 条
[1]  
Abe J, 2016, J PHARM HEALTH CARE, V2, DOI 10.1186/s40780-016-0048-5
[2]  
Arai I, 2020, TRAD KAMPO MED, V7, P3
[3]   LICORICE-INDUCED PSEUDOALDOSTERONISM - HYPERTENSION HYPOKALEMIA ALDOSTERONOPENIA AND SUPPRESSED PLASMA RENIN ACTIVITY [J].
CONN, JW ;
ROVNER, DR ;
COHEN, EL .
JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1968, 205 (07) :492-+
[4]   DIURETIC USE IN THE ELDERLY - POTENTIAL FOR DIURETIC-INDUCED HYPOKALEMIA [J].
FLAMENBAUM, W .
AMERICAN JOURNAL OF CARDIOLOGY, 1986, 57 (02) :A38-A43
[5]   Irinotecan-induced neutropenia is reduced by oral alkalization drugs: analysis using retrospective chart reviews and the spontaneous reporting database [J].
Hamano, Hirofumi ;
Mitsui, Marin ;
Zamami, Yoshito ;
Takechi, Kenshi ;
Nimura, Takahiro ;
Okada, Naoto ;
Fukushima, Keijo ;
Imanishi, Masaki ;
Chuma, Masayuki ;
Horinouchi, Yuya ;
Izawa-Ishizawa, Yuki ;
Kirino, Yasushi ;
Nakamura, Toshimi ;
Teraoka, Kazuhiko ;
Ikeda, Yasumasa ;
Fujino, Hiromichi ;
Yanagawa, Hiroaki ;
Tamaki, Toshiaki ;
Ishizawa, Keisuke .
SUPPORTIVE CARE IN CANCER, 2019, 27 (03) :849-856
[6]   Effects of long term administration of Shakuyaku-kanzo-To and Shosaiko-To on serum potassium levels [J].
Homma, Masato ;
Ishihara, Miya ;
Qian, Wen ;
Kohda, Yukinao .
YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2006, 126 (10) :973-978
[7]  
ISHIDA S, 1988, CHEM PHARM BULL, V36, P440
[8]  
ISHIKAWA S, 1985, ENDOCRINOL JAPON, V32, P793
[9]   18β-glycyrrhetyl-3-O-sulfate would be a causative agent of licorice-induced pseudoaldosteronism [J].
Ishiuchi, Kan'ichiro ;
Morinaga, Osamu ;
Ohkita, Takeshi ;
Tian, Chuanting ;
Hirasawa, Asuka ;
Mitamura, Miaki ;
Maki, Yasuhito ;
Kondo, Tsubasa ;
Yasujima, Tomoya ;
Yuasa, Hiroaki ;
Minamizawa, Kiyoshi ;
Namiki, Takao ;
Makino, Toshiaki .
SCIENTIFIC REPORTS, 2019, 9 (1)
[10]   Pseudoaldosteronism induced by Yokukansan in an elderly Japanese type 2 diabetic patient with Alzheimer's disease [J].
Kamei, Shinji ;
Kaneto, Hideaki ;
Irie, Shintaro ;
Kinoshita, Tomoe ;
Tanabe, Akihito ;
Hirukawa, Hidenori ;
Tatsumi, Fuminori ;
Shimoda, Masashi ;
Kohara, Kenji ;
Mune, Tomoatsu ;
Kaku, Kohei .
JOURNAL OF DIABETES INVESTIGATION, 2015, 6 (04) :487-488